Efficiency of anti‐VEGF therapy in central nervous system AML relapse: A case report and literature review

There have been few reports on the treatment of central nervous system (CNS) acute myeloid leukemia (AML) relapse. This case study demonstrates that bevacizumab may be a viable treatment option when combined with IT chemotherapy as maintenance therapy for those with CNS leukemia.

Detalles Bibliográficos
Autores principales: Cao, Han‐Yu, Tao, Tao, Shen, Xiang‐Dong, Bai, Lian, Wan, Chao‐Ling, Wu, De‐Pei, Li, Jin‐Li, Xue, Sheng‐Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813665/
https://www.ncbi.nlm.nih.gov/pubmed/35140963
http://dx.doi.org/10.1002/ccr3.5367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813665/
https://www.ncbi.nlm.nih.gov/pubmed/35140963
http://dx.doi.org/10.1002/ccr3.5367

Ejemplares similares